Screener
Kestra Medical Technologies KMTS Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 51.4%+10.9pp | 48.8%+15.1pp | 46.4%+21.7pp | 43.5%+30.2pp | 40.5%+39.2pp | |
| Operating margin | -141.6%+36.2pp | -171.5%-11.2pp | -174.3%+19.2pp | -175.9%+68.5pp | -177.8%+128pp | |
| Net margin | -138.4%+51.9pp | -173%-0.8pp | -178%+32.9pp | -180.3%+88.6pp | -190.3%+148pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×-0.1× | —— | —— | —— | 0.4×— | |
| Liquidity | ||||||
| Current ratio | 4.4×-2.3× | 7.3×— | 5.5×— | 6.8×— | 6.7×+6.3× | |
| Valuation | ||||||
| Market capitalization | $1.55B+106% | $1.44B— | $1.41B— | $847.25M— | —— | |
| Price / sales | 16.3×+4.9× | 17.2×— | 19×— | 12.8×— | —— |
FAQ
- What are Kestra Medical Technologies's profit margins?
- Kestra Medical Technologies (KMTS) runs a 51.4% gross margin and a -141.6% operating margin, with a -138.4% net margin.
- Where do Kestra Medical Technologies's ratios come from?
- Every ratio is computed from Kestra Medical Technologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
